Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience

J Infect Dis. 2022 Jan 18;225(2):352-354. doi: 10.1093/infdis/jiab406.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Neoplasms*
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral